EME -A Phase II Randomised Clinical Trial of Conditioning Cyclophosphamide and Chemoembiolisation with or without Vaccination with Dendritic Cells Pulsed with HepG2 Lysate in vivo in Patients with Hepatocellular Carcinoma : IMMUNOTACE Trial

  • Barton, Darren (Co-Investigator)
  • Steven, Neil (Co-Investigator)
  • Adams, David (Principal Investigator)
  • Gough, Rich (Co-Investigator)

Project Details

Short titleEME -A Phase II Randomised Clinical Trial of Conditioning Cyclophosphamide and Chemoembiolisation with or without Vaccination with Dendritic Cells Pulsed with HepG2 Lysate in vivo in Patients with Hepatocellular Carcinoma : IMMUNOTACE Trial
StatusActive
Effective start/end date1/01/13 → 31/12/25

Funding

  • NIHR